Autoimmune signals in non‐segmental vitiligo patients are associated with distinct clinical parameters and toxic exposures
M. Arunachalam(University of Florence), Silvia Moretti(University of Insubria), Federica Dragoni(University of Florence), Roberta Colucci(University of Florence), S. Berti(University of Florence), Jeffrey A. Kline(Carolinas Medical Center), Francesco Lotti(University of Florence), Torello Lotti(University of Zurich)
Journal of the European Academy of Dermatology and Venereology
June 15, 2012
Cited by 8
Related Papers
BMI in relation to sperm count: an updated systematic review and collaborative meta-analysis
|Human Reproduction Update|2012|655
Guidelines for the management of vitiligo: the European Dermatology Forum consensus
|British Journal of Dermatology|2012|446
Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants
|Nature Genetics|2016|362
New Insights into the Pathogenesis of Vitiligo: Imbalance of Epidermal Cytokines at Sites of Lesions
|Pigment Cell Research|2002|298
Chilblain‐like lesions during COVID‐19 epidemic: a preliminary study on 63 patients
|Journal of the European Academy of Dermatology and Venereology|2020|248